Cartesian Therapeutics
RNAC
#6732
Rank
A$0.71 B
Marketcap
$29.85
Share price
3.61%
Change (1 day)
-41.09%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2023 (TTM): -$0.48

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.48. In 2021 the company made an earnings per share (EPS) of -$0.36 an increase over its 2020 EPS that were of -$1.04.

EPS history for Cartesian Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.48
2021-$0.36-65.22%
2020-$1.04-43.44%
2019-$1.84-58.08%
2018-$4.39-9.35%
2017-$4.84-29.16%
2016-$6.83